zoledronic acid

This page covers all zoledronic acid drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Farnesyl pyrophosphate synthase.

Targets

Farnesyl pyrophosphate synthase

Marketed (1)

• Zometa · Novartis · Oncology
  Zometa works by inhibiting the enzyme farnesyl pyrophosphate synthase, which is involved in the mevalonate pathway and ultimately leads to the inhibition of osteoclast activity.

Patent intelligence

• zoledronic acid patent landscape — aggregated cliff calendar, attackable patents, originator estates